Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Celgene and Forma enter second collaboration; Celgene gets buy-out option

Executive Summary

Celgene Corp. and drug discovery firm Forma Therapeutics Holdings LLC entered into their second partnership in just a year, this time teaming up for the discovery and development of compounds spanning a variety of therapeutic areas including cancer, with the potential for Celgene to buy Forma outright at the end of a possible seven-and-a-half year term.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes M&A Option
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies